Résultats de la recherche - 7 results

Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.

Publication Type: Peer reviewed scientific article Authors: Polman, N J; Oštrbenk, A; Lan Xu; Snijders, P J F; Meijer, C J L M; Poljak, M; Heideman, D A M; M. Arbyn Source: J Clin Microbiol (2017) ...

Why follow-back studies should be interpreted cautiously: The case of an HPV-negative cervical lesion.

Publication Type: Peer reviewed scientific article Authors: Rossi, Paolo Giorgi; Ronco, Guglielmo; Dillner, Joakim; K Miriam Elfström; Snijders, Peter J F; M. Arbyn; Berkhof, Johannes; Carozzi, ...

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Snijders, P J F; Meijer, C J L M; Berkhof, J; Cuschieri, K; Kocjan, B J; Poljak, M Source: Clin Microbiol Infect, Volume 21, ...

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Snijders, Peter J F; Meijer, C.J.L.M.; Berkhof, J; Cuschieri, K.; Kocjan, B.J.; Poljak, M Source: Clinical Microbiology and ...

Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.

Publication Type: Peer reviewed scientific article Authors: Geraets, D T; Cuschieri, K; de Koning, M N C; van Doorn, L J; Snijders, P J F; Meijer, C J L M; Quint, W G V; M. Arbyn Source: J Clin ...

QR code

QR code for this page URL